IFNA1 and Dravet syndrome: These results support the notion that elevated IFN signaling during embryonic development could impair organogenesis (51, 52), while suggesting that individuals with DS who experienced high IFN activity in utero would be more likely to have both a history of CHD and AITD and stronger IFN hyperactivity later in life.